Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast Cancer
Phase 3 Terminated
55 enrolled
Study of Vudalimab or Pembrolizumab in Combination With Chemotherapy as First-line Treatment in Patients With Advanced NSCLC
Phase 1/2 Terminated
28 enrolled
A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer
Phase 2 Terminated
50 enrolled 18 charts
Study of AK119 and AK112 With or Without Chemotherapy for NSCLC Patients
Phase 1/2 Terminated
59 enrolled
AcceleRET-Lung
Phase 3 Terminated
223 enrolled 18 charts
A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors
Phase 1 Terminated
157 enrolled
Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus.
Phase 2 Terminated
71 enrolled
Study of Oral Debio 0123 in Combination With Carboplatin in Participants With Advanced Solid Tumors
Phase 1 Terminated
76 enrolled
A Study to Evaluate PK, Efficacy, and Safety of BAT3306 Plus Chemo and Compare With Keytruda®(EU/US) in Participants With IV nqNSCLC
Phase 3 Terminated
162 enrolled
(VELA) Study of BLU-222 in Advanced Solid Tumors
Phase 1 Terminated
50 enrolled
A Study Comparing Niraparib Versus Platinum-Taxane Doublet Chemotherapy as Neoadjuvant Treatment in Participants With Homologous Recombination-Deficient Stage III/IV Ovarian Cancer (COHORT-C)
Phase 2 Terminated
36 enrolled 11 charts
ELEVATE HNSCC
Phase 2 Terminated
193 enrolled 27 charts
Pemigatinib + Pembrolizumab vs Pemigatinib Alone vs Standard of Care for Urothelial Carcinoma (FIGHT-205)
Phase 2 Terminated
7 enrolled 10 charts
CARMEN-LC05
Phase 2 Terminated
57 enrolled 26 charts
A Clinical Study of Bemcentinib With Standard of Care Chemoimmunotherapy in Untreated Advanced/Metastatic Non-small Cell Lung Cancer Patients With a Mutation in the STK11 Gene
Phase 1/2 Terminated
26 enrolled 13 charts
Leronlimab (PRO 140) Combined With Carboplatin in Patients With Cytokine Chemokine Receptor 5 Positive (CCR5+) mTNBC
Phase 1/2 Terminated
10 enrolled 15 charts
PRESERVE3
Phase 2 Terminated
92 enrolled 24 charts
A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors
Phase 1 Terminated
94 enrolled 28 charts
BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced or Recurrent dMMR Endometrial Cancer
Phase 2/3 Terminated
5 enrolled
Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumors
Phase 1/2 Terminated
125 enrolled
A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors
Phase 1 Terminated
105 enrolled
Phase II Study of SHR-1210(Anti-PD-1 Antibody) Combination With Apatinib Versus Pemetrexed and Carboplatin in Subjects With KRAS Mutant Stage IV Non-squamous Non-small Cell Lung Cancer
Phase 2 Terminated
25 enrolled
A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)
Phase 2 Terminated
1 enrolled 4 charts
CONTERNO
Phase 3 Terminated
25 enrolled 10 charts
FORTITUDE-201
Phase 1 Terminated
74 enrolled 22 charts
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411
Phase 1/2 Terminated
54 enrolled 30 charts
A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer
Phase 1/2 Terminated
36 enrolled 26 charts
(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations
Phase 1 Terminated
103 enrolled
A Study of Rebastinib (DCC-2036) in Combination With Carboplatin in Patients With Advanced or Metastatic Solid Tumors
Phase 1/2 Terminated
70 enrolled 24 charts
VELIA
Phase 3 Terminated
1,140 enrolled 29 charts
A BRIDGING STUDY OF PF-06439535 (CN) PLUS PACLITAXEL-CARBOPLATIN VERSUS BEVACIZUMAB PLUS PACLITAXEL-CARBOPLATIN IN NSCLC
Phase 3 Terminated
8 enrolled 6 charts
QUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer
Phase 1/2 Terminated
15 enrolled 11 charts
Study to Assess the Effects of GS-3583 in Participants With Advanced Solid Tumors
Phase 1 Terminated
13 enrolled 18 charts
SCLC
Phase 1/2 Terminated
213 enrolled 16 charts
Aumolertinib With Chemotherapy or Alone Compared With Osimertinib in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer
Phase 3 Terminated
8 enrolled 7 charts
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Terminated
22 enrolled
A Study of Anti-PD-1 AK105 in Patients With Metastatic Nonsquamous Non-small Cell Lung Cancer
Phase 3 Terminated
164 enrolled
REPLATINUM
Phase 3 Terminated
18 enrolled
A Study to Evaluate the Combination of ATX-101 and Platinum-based Chemotherapy
Phase 1/2 Terminated
16 enrolled
M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)
Phase 2 Terminated
153 enrolled 13 charts
UPGRADE
Phase 1 Terminated
31 enrolled
Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies
Phase 1/2 Terminated
67 enrolled 24 charts
E7080 in Combination With Carboplatin + Gemcitabine Versus Carboplatin + Gemcitabine Alone as Second Line Therapy in Patients With Platinum-Sensitive Recurrent Ovarian Cancer by CA125
Phase 1/2 Terminated
7 enrolled 6 charts
(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC
Phase 1 Terminated
20 enrolled
PROPEL
Phase 1/2 Terminated
162 enrolled 21 charts
KN046 in Patients With Advanced Non-small Cell Lung Cancer
Phase 2 Terminated
120 enrolled
Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse
Phase 3 Terminated
1,100 enrolled 30 charts
NTX-301 Monotherapy in Advanced Solid Tumours and in Combination With Platinum-based Chemotherapy in Advanced Ovarian & Bladder Cancer and in Combination With Temozolomide in High-grade Glioma
Phase 1/2 Terminated
12 enrolled
A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection)
Phase 1 Terminated
35 enrolled
IBI188 Combination Therapy in Solid Tumors
Phase 1 Terminated
9 enrolled